Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High COVID-19 vaccine coverage allows for a re-opening of European universities

View ORCID ProfileJana Lasser, Timotheus Hell, View ORCID ProfileDavid Garcia
doi: https://doi.org/10.1101/2021.11.16.21266383
Jana Lasser
aGraz University of Technology, Institute for Interactive Systems and Data Science, Inffeldgasse 16C, 8010 Graz, Austria
bComplexity Science Hub Vienna, Josefstädterstraße 39, 1080 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jana Lasser
  • For correspondence: jana.lasser@tugraz.at
Timotheus Hell
cGraz University of Technology, Higher Education and Programme Development, Rechbauerstraße 12, 8010 Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Garcia
aGraz University of Technology, Institute for Interactive Systems and Data Science, Inffeldgasse 16C, 8010 Graz, Austria
bComplexity Science Hub Vienna, Josefstädterstraße 39, 1080 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Garcia
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Returning universities to full on-campus operations while the COVID-19 pandemic is ongoing has been a controversial discussion in many countries. The risk of large outbreaks in dense course settings is contrasted by the benefits of in-person teaching. Transmission risk depends on a range of parameters, such as vaccination coverage, number of contacts and adoption of non-pharmaceutical intervention measures (NPIs). Due to the generalised academic freedom in Europe, many universities are asked to autonomously decide on and implement intervention measures and regulate on-campus operations. In the context of rapidly changing vaccination coverage and parameters of the virus, universities often lack the scientific facts to base these decisions on. To address this problem, we analyse a calibrated, data-driven simulation of transmission dynamics of 10755 students and 974 faculty in a medium-sized university. We use a co-location network reconstructed from student enrolment data and calibrate transmission risk based on outbreak size distributions in other Austrian education institutions. We focus on actionable interventions that are part of the already existing decision-making process of universities to provide guidance for concrete policy decisions. Here we show that with the vaccination coverage of about 80% recently reported for students in Austria, universities can be safely reopened if they either mandate masks or reduce lecture hall occupancy to 50%. Our results indicate that relaxing NPIs within an organisation based on the vaccination coverage of its sub-population can be a way towards limited normalcy, even if nation wide vaccination coverage is not sufficient to prevent large outbreaks yet.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • JL developed the research idea, implemented the simulation and wrote the initial draft of the manuscript. TH helped acquire the relevant data to construct the university contact network and defined scenarios relevant for university policy. DG provided guidance on the research questions and statistical analysis of simulation outcomes. All authors have read and edited the final manuscript.

  • The authors declare no competing interests.

  • ↵* We use the implementation of the algorithm provided by the Python networkx package: https://networkx.org/documentation/stable/reference/algorithms/generated/networkx.algorithms.community.quality.modularity.html

Data Availability

All data produced are available online at https://doi.org/10.17605/OSF.IO/UPX7R

https://doi.org/10.17605/OSF.IO/UPX7R

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 16, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High COVID-19 vaccine coverage allows for a re-opening of European universities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High COVID-19 vaccine coverage allows for a re-opening of European universities
Jana Lasser, Timotheus Hell, David Garcia
medRxiv 2021.11.16.21266383; doi: https://doi.org/10.1101/2021.11.16.21266383
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
High COVID-19 vaccine coverage allows for a re-opening of European universities
Jana Lasser, Timotheus Hell, David Garcia
medRxiv 2021.11.16.21266383; doi: https://doi.org/10.1101/2021.11.16.21266383

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4662)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)